News

We are looking for a R&D Microbiologist

Oct 13, 2020

WHAT WE OFFER

An exciting opportunity to dive in your career with a company that have the ambition to be the leader in its domain. We will give you the mean to make your contribution highly impactful.

Ysopia Bioscience is a French biotech based in Bordeaux developing microbiome-based therapeutics. Working at Ysopia Bioscience is an opportunity to contribute to the development of next generation therapeutics. You will enjoy working with an enthusiastic team committed to delivering disruptive and outstanding products that will impact numerous patients.

Ysopia is looking for an outstanding microbiologist with expertise in anaerobic culture of micro-organisms. You will be part of the R&D team and work in close interaction with other scientists and project managers. You will work under the direct supervision of the Chief Scientific Officer. You are rigorous, organized, autonomous and like teamwork. You have proven experience working with anaerobic micro-organisms.

 

Responsabilities

  • Manage the bacterial strain collection of Ysopia Bioscience
  • Characterise and study micro-organisms using appropriate methods
  • Set up/Optimise/Suggest appropriate experimental protocols
  • Record data following appropriate procedures
  • Analyse and interpret results
  • Write up documents
  • Communicate within your team and with project managers
  • Take part in day to day laboratory activities

 

Education

  • PhD in microbiology or equivalent
  • Minimum 3 years experience working in an R&D laboratory
  • Good English skills (oral and written)
  • Experience working with anaerobic micro-organisms
  • Good knowledge of sequencing technologies and associated data analysis would be preferable

 

Job starting date: January 2021
Location: Bordeaux, France

To apply for this opportunity, please send your resume and a cover letter to recruitment@ysopia.bio

In the same category

News

YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional...

Nov 17, 2020

more +
News

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020

more +
News

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

more +

YSOPIA Bioscience © 2020 - all rights reserved terms and conditions